Soundbite is a medical devices company, Montreal and Sherbrooke-based, developing and commercializing proprietary wire-based devices and generator technology that delivers shockwave energy within the cardiovascular system to treat chronic total occlusions (CTO’s).
The company will target CTO’s in patients with peripheral artery disease (PAD) and coronary artery disease (CAD), disease states that affect over 12 million and 8 million Americans, respectively.
Soundbite has developed a proprietary method to produce and focus shockwaves into wire-based devices of 0.014” and 0.018” size.
Device sizes are compatible with standard angioplasty platforms.
The energy produced helps power through calcium and fibrotic deposits.
Shockwaves are believed to be benign to healthy elastic tissue